pdf,doi,supplementary,authors,title,journal,year,page,access,name_cocrystal,name_cocrystal_type_file,name_cocrystal_page,name_cocrystal_origin,ratio_cocrystal,ratio_cocrystal_page,ratio_cocrystal_page.1,ratio_cocrystal_origin,name_drug,name_drug_type_file,name_drug_origin,name_drug_page,SMILES_drug,SMILES_drug_type_file,SMILES_drug_origin,SMILES_drug_page,name_coformer,name_coformer_type file,name_coformer_origin,name_coformer_page,SMILES_coformer,SMILES_coformer_type file,SMILES_coformer_origin,SMILES_coformer_page,photostability_change,photostability_change_type_file,photostability_change_origin,photostability_change_page
Wang2024,10.1016/j.molstruc.2024.139270,1,"Z. Wang, S. Li, Y. Tao, R. Zheng, S. Yang, D. Yang, S. Wang, L. Zhang, J. Xing, G. Du, Y. Lu","The novel cocrystals of acacetin with 4,4 ?-bipyridine and 2,2-bipyridine: Crystal structures analysis, stability and dissolution evaluation",Journal of Molecular Structure,2024,139270,0,"ACT-4,4′-BPY",manuscript,text,2,2:1,manuscript,text,2,Acacetin,manuscript,text,1,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1,manuscript,figure 1,2,"4,4'-Bipyridine",manuscript,text,2,c1cc(-c2ccncc2)ccn1,manuscript,figure 1,2,does not change,manuscript,text,9
Wang2024,10.1016/j.molstruc.2024.139270,1,"Z. Wang, S. Li, Y. Tao, R. Zheng, S. Yang, D. Yang, S. Wang, L. Zhang, J. Xing, G. Du, Y. Lu","The novel cocrystals of acacetin with 4,4 ?-bipyridine and 2,2-bipyridine: Crystal structures analysis, stability and dissolution evaluation",Journal of Molecular Structure,2024,139270,0,"ACT-2,2′-BPY",manuscript,text,2,2:1,manuscript,text,2,Acacetin,manuscript,text,1,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1,manuscript,figure 1,2,"2,2'-Bipyridine",manuscript,text,2,c1ccc(-c2ccccn2)nc1,manuscript,figure 1,2,does not change,manuscript,text,9
Yutani2019,10.3390/cryst9110553,0,"Reiko Yutani, Ryotaro Haku, Reiko Teraoka, Chisato Tode, Tatsuo Koide, Shuji Kitagawa, Toshiyasu Sakane, Toshiro Fukami",Comparative Evaluation of the Photostability of Carbamazepine Polymorphs and Cocrystals,Crystals,2019,553,1,CBZ–SUC,manuscript,text,1,2:1,manuscript,text,3,Carbamazepine,manuscript,text,1,NC(=O)N1c2ccccc2C=Cc2ccccc21,manuscript,figure 1,2,succinic acid,manuscript,text,2,O=C(O)CCC(=O)O,manuscript,figure 1,2,increases,manuscript,figure 4,7
Yutani2019,10.3390/cryst9110553,0,"Reiko Yutani, Ryotaro Haku, Reiko Teraoka, Chisato Tode, Tatsuo Koide, Shuji Kitagawa, Toshiyasu Sakane, Toshiro Fukami",Comparative Evaluation of the Photostability of Carbamazepine Polymorphs and Cocrystals,Crystals,2019,553,1,CBZ–SAC Form I,manuscript,text,1,1:1,manuscript,text,3,Carbamazepine,manuscript,text,1,NC(=O)N1c2ccccc2C=Cc2ccccc21,manuscript,figure 1,2,saccharin,manuscript,text,1,O=C1NS(=O)(=O)c2ccccc21,manuscript,figure 1,2,increases,manuscript,figure 4,7
Yutani2019,10.3390/cryst9110553,0,"Reiko Yutani, Ryotaro Haku, Reiko Teraoka, Chisato Tode, Tatsuo Koide, Shuji Kitagawa, Toshiyasu Sakane, Toshiro Fukami",Comparative Evaluation of the Photostability of Carbamazepine Polymorphs and Cocrystals,Crystals,2019,553,1,CBZ–SAC Form II,manuscript,text,1,1:1,manuscript,text,3,Carbamazepine,manuscript,text,1,NC(=O)N1c2ccccc2C=Cc2ccccc21,manuscript,figure 1,2,saccharin,manuscript,text,1,O=C1NS(=O)(=O)c2ccccc21,manuscript,figure 1,2,decrease,manuscript,figure 4,7
Eesam2020,10.1186/s43094-020-00083-5,0,"Shivarani Eesam, Jaswanth S. Bhandaru, Chandana Naliganti, Ravi Kumar Bobbala, Raghuram Rao Akkinepally",Solubility enhancement of carvedilol using drug–drug cocrystallization with hydrochlorothiazide,Future Journal of Pharmaceutical Sciences,2020,1,1,CAR-HCT,manuscript,text,3,2:0.5,manuscript,text,3,carvedilol,manuscript,text,1,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,manuscript,figure 1,3,hydrochlorothiazide,manuscript,text,1,NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O,manuscript,figure 2,3,,,,
Ma2021,10.1039/d0ce01551b,1,"Xiaoyu Ma, Bingqing Zhu, Zeen Yang, Yuhang Jianga, Xuefeng Mei",Stabilizing photo-sensitive colchicine through rebalancing electron distribution of the reactive tropolone ring,CrystEngComm,2021,30,0,Col–BSA,manuscript,text,2,1:1,supporting information,text,1,colchicine,manuscript,text,1,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,manuscript,scheme 1,1,benzenesulfonic acid,manuscript,text,2,O=S(=O)(O)c1ccccc1,supporting information,table S1,4,increases,manuscript,figure 3,3
Ma2021,10.1039/d0ce01551b,1,"Xiaoyu Ma, Bingqing Zhu, Zeen Yang, Yuhang Jianga, Xuefeng Mei",Stabilizing photo-sensitive colchicine through rebalancing electron distribution of the reactive tropolone ring,CrystEngComm,2021,30,0,Col–PTA,manuscript,text,2,1:1,supporting information,text,1,colchicine,manuscript,text,1,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,manuscript,scheme 1,1,p-toluenesulfonic acid,manuscript,text,2,Cc1ccc(S(=O)(=O)O)cc1,supporting information,table S1,4,increases,manuscript,figure 3,3
Ma2021,10.1039/d0ce01551b,1,"Xiaoyu Ma, Bingqing Zhu, Zeen Yang, Yuhang Jianga, Xuefeng Mei",Stabilizing photo-sensitive colchicine through rebalancing electron distribution of the reactive tropolone ring,CrystEngComm,2021,30,0,Col–BSA,manuscript,text,2,1:1,supporting information,text,1,colchicine,manuscript,text,1,COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1C(NC(C)=O)CC2,manuscript,scheme 1,1,2-naphthalenesulfonic acid,manuscript,text,2,O=S(=O)(O)c1ccc2ccccc2c1,supporting information,table S1,4,increases,manuscript,figure 3,3
Diniz2024,10.1021/acs.molpharmaceut.4c00393,1,"Luan F. Diniz, Paulo S. Carvalho Jr., Mateus A. C. Souza, Renata Diniz, Christian Fernandes",Highly Soluble Dacarbazine Multicomponent Crystals Less Prone to Photodegradation,Molecular Pharmaceutics,2024,3661,1,DTIC-HOXA,manuscript,text,1,1:1,supporting information,table S4,12,Dacarbazine,manuscript,text,1,CN(C)N=Nc1[nH]cnc1C(N)=O,manuscript,scheme 1,1,oxalic acid,manuscript,text,2,O=C(O)C(=O)O,manuscript,scheme 1,1,does not change,manuscript,figure 7c,10
Diniz2024,10.1021/acs.molpharmaceut.4c00393,1,"Luan F. Diniz, Paulo S. Carvalho Jr., Mateus A. C. Souza, Renata Diniz, Christian Fernandes",Highly Soluble Dacarbazine Multicomponent Crystals Less Prone to Photodegradation,Molecular Pharmaceutics,2024,3661,1,DTIC-HMAL,manuscript,text,1,1:1,supporting information,table S4,12,Dacarbazine,manuscript,text,1,CN(C)N=Nc1[nH]cnc1C(N)=O,manuscript,scheme 1,1,maleic acid,manuscript,text,2,O=C(O)/C=C\C(=O)O,manuscript,scheme 1,1,does not change,manuscript,figure 7c,10
Diniz2024,10.1021/acs.molpharmaceut.4c00393,1,"Luan F. Diniz, Paulo S. Carvalho Jr., Mateus A. C. Souza, Renata Diniz, Christian Fernandes",Highly Soluble Dacarbazine Multicomponent Crystals Less Prone to Photodegradation,Molecular Pharmaceutics,2024,3661,1,DTIC-H2FUM,manuscript,text,1,1:1,supporting information,table S4,12,Dacarbazine,manuscript,text,1,CN(C)N=Nc1[nH]cnc1C(N)=O,manuscript,scheme 1,1,fumaric acid,manuscript,text,2,O=C(O)/C=C/C(=O)O,manuscript,scheme 1,1,does not change,manuscript,figure 7c,10
Diniz2024,10.1021/acs.molpharmaceut.4c00393,1,"Luan F. Diniz, Paulo S. Carvalho Jr., Mateus A. C. Souza, Renata Diniz, Christian Fernandes",Highly Soluble Dacarbazine Multicomponent Crystals Less Prone to Photodegradation,Molecular Pharmaceutics,2024,3661,1,DTIC-H2SUС,manuscript,text,1,1:1,supporting information,table S4,12,Dacarbazine,manuscript,text,1,CN(C)N=Nc1[nH]cnc1C(N)=O,manuscript,scheme 1,1,succinic acid,manuscript,text,2,O=C(O)CCC(=O)O,manuscript,scheme 1,1,does not change,manuscript,figure 7c,10
Diniz2024,10.1021/acs.molpharmaceut.4c00393,1,"Luan F. Diniz, Paulo S. Carvalho Jr., Mateus A. C. Souza, Renata Diniz, Christian Fernandes",Highly Soluble Dacarbazine Multicomponent Crystals Less Prone to Photodegradation,Molecular Pharmaceutics,2024,3661,1,DTIC-HCIT,manuscript,text,1,2:1,supporting information,table S4,12,Dacarbazine,manuscript,text,1,CN(C)N=Nc1[nH]cnc1C(N)=O,manuscript,scheme 1,1,citric acid,manuscript,text,2,O=C(O)CC(O)(CC(=O)O)C(=O)O,manuscript,scheme 1,1,does not change,manuscript,figure 7c,10
Hao2022,10.1039/D2CE00597B,1,"Xinghui Hao,Jinhui Li, Chenguang Wang, Xinghua Zhao, Xin He, Changquan Calvin Sun",Profoundly improved photostability of dimetronidazole by cocrystallization,CrystEngComm,2022,6165,0,DMZ-SAC,manuscript,text,2,1:1,manuscript,text,1,Dimetronidazole,manuscript,text,1,Cc1ncc([N+](=O)[O-])n1C,manuscript,scheme 1,1,saccharin,manuscript,text,1,O=C1NS(=O)(=O)c2ccccc21,manuscript,scheme 1,1,increases,manuscript,figure 7c,6
Putra2018,10.1021/acs.cgd.7b01371,1,"Okky Dwichandra Putra, Daiki Umeda, Yuda Prasetya Nugraha, Kazuya Nango, Etsuo Yonemochi, Hidehiro Uekusa",Simultaneous Improvement of Epalrestat Photostability and Solubility via Cocrystallization: A Case Study,Crystal Growth & Design,2018,373,0,EPR-BET,manuscript,text,3,1:1,manuscript,text,2,Epalrestat,manuscript,text,1,CC(=C\c1ccccc1)/C=C1/SC(=S)N(CC(=O)O)C1=O,manuscript,chart 1,1,betaine,manuscript,text,1,C[N+](C)(C)CC(=O)[O-],manuscript,chart 1,1,increases,manuscript,text,6
Li2022,10.1021/acs.cgd.2c00533,1,"Min Li, Jingjing Sun, Wenjie Kuang, Lina Zhou, Dandan Han, Junbo Gong",Drug–Drug Multicomponent Crystals of Epalrestat: A Novel Form of the Drug Combination and Improved Solubility and Photostability of Epalrestat,Crystal Growth & Design,2022,5027,0,EP-ED,manuscript,text,2,1:1,manuscript,text,4,Epalrestat,manuscript,text,1,CC(=C\c1ccccc1)/C=C1/SC(=S)N(CC(=O)O)C1=O,manuscript,scheme 1,2,edaravone,manuscript,text,1,CC1=NN(c2ccccc2)C(=O)C1,manuscript,scheme 1,2,increases,manuscript,text,5
Li2022,10.1021/acs.cgd.2c00533,1,"Min Li, Jingjing Sun, Wenjie Kuang, Lina Zhou, Dandan Han, Junbo Gong",Drug–Drug Multicomponent Crystals of Epalrestat: A Novel Form of the Drug Combination and Improved Solubility and Photostability of Epalrestat,Crystal Growth & Design,2022,5027,0,EP-PR SC MH,manuscript,text,2,,,,,Epalrestat,manuscript,text,1,CC(=C\c1ccccc1)/C=C1/SC(=S)N(CC(=O)O)C1=O,manuscript,scheme 1,2,pregabalin,manuscript,text,1,CC(C)CC(CN)CC(=O)O,manuscript,scheme 1,2,increases,manuscript,text,5
Sun2025,10.1016/j.molstruc.2025.141678,1,"Zhong-hua Sun, Zhao Yang, Yan Zhang, Hong Xu, Ru-mei Liu, Da-zhong Ding, Yang Li f, Yun-jie Zhu, Min Li, Ping Leng","Synthesis, characterization, solubility and photostability enhancement of felodipine co-crystals featuring a novel single-crystal structure",Journal of Molecular Structure,2025,141678,0,FEL–BPE,manuscript,text,1,,,,,felodipine,manuscript,text,1,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl,manuscript,figure 1,2,"1,2-bis(4-pyridyl)ethylene",manuscript,text,1,c1cc(CCc2ccncc2)ccn1,manuscript,figure 1,2,increases,manuscript,table 4,7
Liu2024,10.1016/j.ejpb.2024.114464,1,"Lixin Liu, Yuning Wang, Jiuyi Sun, Yunan Zhang, Xiangyu Zhang, Lili Wu, Yingli Liu, Xuan Zhang, Yidi Xia, Qiumei Zhang, Ning Gao","Improved photostability, solubility, hygroscopic stability and antimicrobial activity of fleroxacin by synthesis of fleroxacin-D-tartaric acid pharmaceutical salt",European Journal of Pharmaceutics and Biopharmaceutics,2024,114464,0,FL-D-TT,manuscript,text,1,1:1,,,,fleroxacin,manuscript,text,1,CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1,manuscript,scheme 1,2,D-tartaric,manuscript,text,1,O=C(O)C(O)C(O)C(=O)O,manuscript,scheme 1,2,increases,manuscript,figure 14,8
AbrahamMiranda2019,10.1021/acs.cgd.8b01556,1,"Julieta Abraham Miranda, Claudia Garnero, Ana K. Chattah, Yara Santiago de Oliveira, Alejandro P. Ayala, Marcela R. Longhi",Furosemide:Triethanolamine Salt as a Strategy To Improve the Biopharmaceutical Properties and Photostability of the Drug,Crystal Growth & Design,2019,2060,0,FUR:TEA,manuscript,text,2,1:1,,,,Furosemide,manuscript,text,1,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,manuscript,scheme 1,1,triethanolamine,manuscript,text,2,OCCN(CCO)CCO,manuscript,scheme 1,1,increases,manuscript,table 2,7
Teraoka2019,10.1248/cpb.c18-00812,0,"Reiko Teraoka, Toshiro Fukami, Takayuki Furuishi, Hiromasa Nagase, Haruhisa Ueda, Chisato Tode, Reiko Yutani, Shuji Kitagawa, Toshiyasu Sakane",Improving the Solid-State Photostability of Furosemide by Its Cocrystal Formation,Chemical and Pharmaceutical Bulletin,2019,940,1,FUR-CAF,manuscript,text,1,1 : 1,manuscript,text,1,Furosemide,manuscript,text,1,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,manuscript,chart 1,2,caffeine,manuscript,text,1,Cn1c(=O)c2c(ncn2C)n(C)c1=O,manuscript,chart 1,2,increases,manuscript,figure 3,4
Teraoka2019,10.1248/cpb.c18-00812,0,"Reiko Teraoka, Toshiro Fukami, Takayuki Furuishi, Hiromasa Nagase, Haruhisa Ueda, Chisato Tode, Reiko Yutani, Shuji Kitagawa, Toshiyasu Sakane",Improving the Solid-State Photostability of Furosemide by Its Cocrystal Formation,Chemical and Pharmaceutical Bulletin,2019,940,1,FUR-UREA,manuscript,text,1,1 : 1,manuscript,text,1,Furosemide,manuscript,text,1,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,manuscript,chart 1,2,urea,manuscript,text,1,NC(N)=O,manuscript,chart 1,2,decreases,manuscript,figure 3,4
Teraoka2019,10.1248/cpb.c18-00812,0,"Reiko Teraoka, Toshiro Fukami, Takayuki Furuishi, Hiromasa Nagase, Haruhisa Ueda, Chisato Tode, Reiko Yutani, Shuji Kitagawa, Toshiyasu Sakane",Improving the Solid-State Photostability of Furosemide by Its Cocrystal Formation,Chemical and Pharmaceutical Bulletin,2019,940,1,FUR-NIC,manuscript,text,1,1 : 1,manuscript,text,1,Furosemide,manuscript,text,1,NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,manuscript,chart 1,2,nicotinamide,manuscript,text,1,NC(=O)c1cccnc1,manuscript,chart 1,2,increases,manuscript,figure 3,4
Shinozaki2019,10.1016/j.xphs.2019.02.014,0,"Taeko Shinozaki, Makoto Ono, Kenjirou Higashi, Kunikazu Moribe",A Novel Drug-Drug Cocrystal of Levofloxacin and Metacetamol: Reduced Hygroscopicity and Improved Photostability of Levofloxacin,Journal of Pharmaceutical Sciences,2019,2383,0,LVFX-AMAP,manuscript,text,1,1:1,manuscript,text,1,Levofloxacin,manuscript,text,1,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,manuscript,figure 1,2,metacetamol,manuscript,text,1,CC(=O)Nc1cccc(O)c1,manuscript,figure 1,2,increases,manuscript,table 1,7
Nugrahani2023,10.3390/pharmaceutics15010124,0,"Ilma Nugrahani, Muhammad Ramadhan Sulaiman, Slamet Ibrahim","Stability and Antibiotic Potency Improvement of Levofloxacin by Producing New Salts with 2,6- and 3,5-Dihydroxybenzoic Acid and Their Comprehensive Structural Study",Pharmaceutics,2023,124,1,LF-26,manuscript,text,1,1:1,manuscript,text,1,Levofloxacin,manuscript,text,1,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,manuscript,figure 7,10,"2,6-dihydroxybenzoic acid",manuscript,text,1,O=C(O)c1c(O)cccc1O,manuscript,figure 7,10,increases,manuscript,figure 11,15
Nugrahani2023,10.3390/pharmaceutics15010124,0,"Ilma Nugrahani, Muhammad Ramadhan Sulaiman, Slamet Ibrahim","Stability and Antibiotic Potency Improvement of Levofloxacin by Producing New Salts with 2,6- and 3,5-Dihydroxybenzoic Acid and Their Comprehensive Structural Study",Pharmaceutics,2023,124,1,LF-35,manuscript,text,1,1:1,manuscript,text,1,Levofloxacin,manuscript,text,1,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,manuscript,figure 7,10,"3,5-dihydroxybenzoic acid",manuscript,text,1,O=C(O)c1cc(O)cc(O)c1,manuscript,figure 7,10,increases,manuscript,figure 11,15
Nugrahani2024,10.1016/j.heliyon.2024.e33280,1,"Ilma Nugrahani, Hidehiro Uekusa, Hironaga Oyama, Agnesya Namira Laksana","New proportion of levofloxacin citrate: Structural, physicochemical properties, and potency studies",Heliyon,2024,,1,LF – CA,manuscript,text,1,2:1,manuscript,table 1,6,Levofloxacin,manuscript,text,1,C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23,,,,citric acid,manuscript,text,1,O=C(O)CC(O)(CC(=O)O)C(=O)O,,,,increases,manuscript,figure 11,12
Xie2024,10.3390/molecules29102208,0,"Yifei Xie, Lixiang Gong, Yue Tao, Baoxi Zhang, Li Zhang, Shiying Yang, Dezhi Yang, Yang Lu, Guanhua Du",NewCocrystals of Ligustrazine: Enhancing Hygroscopicity and Stability,Molecules,2024,2208,1,TMP-PABA,manuscript,text,1,1:2,manuscript,text,1,ligustrazine,manuscript,text,1,Cc1nc(C)c(C)nc1C,manuscript,figure 1,2,P-aminobenzoic acid,manuscript,text,1,Nc1ccc(C(=O)O)cc1,manuscript,figure 1,2,increases,manuscript,text,9
Xie2024,10.3390/molecules29102208,0,"Yifei Xie, Lixiang Gong, Yue Tao, Baoxi Zhang, Li Zhang, Shiying Yang, Dezhi Yang, Yang Lu, Guanhua Du",NewCocrystals of Ligustrazine: Enhancing Hygroscopicity and Stability,Molecules,2024,2208,1,TMP-MABA,manuscript,text,1,1.5:1,manuscript,text,1,ligustrazine,manuscript,text,1,Cc1nc(C)c(C)nc1C,manuscript,figure 1,2,3-Aminobenzoic acid,manuscript,text,1,Nc1cccc(C(=O)O)c1,manuscript,figure 1,2,increases,manuscript,text,9
Xie2024,10.3390/molecules29102208,0,"Yifei Xie, Lixiang Gong, Yue Tao, Baoxi Zhang, Li Zhang, Shiying Yang, Dezhi Yang, Yang Lu, Guanhua Du",NewCocrystals of Ligustrazine: Enhancing Hygroscopicity and Stability,Molecules,2024,2208,1,TMP-DNBA,manuscript,text,1,0.5:1,manuscript,text,1,ligustrazine,manuscript,text,1,Cc1nc(C)c(C)nc1C,manuscript,figure 1,2,"3,5-Dinitrobenzoic acid",manuscript,text,1,O=C(O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1,manuscript,figure 1,2,increases,manuscript,text,9
Zheng2024,10.1021/acsomega.4c03864,1,"Chenxuan Zheng, Hao Wang, Ziyao Xiao, Zhixiong Sun, Junjie Bao, Wenjuan Dai, Qi Zhang, Xuefeng Mei",Cocrystal of Lutein with Improved Stability and Bioavailability,ACS Omega,2024,36389,1,PLT-APC,manuscript,text,2,1:1,manuscript,text,5,Lutein,manuscript,text,1,CC1=CC(O)CC(C)(C)C1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C,manuscript,scheme 1,1,adipic acid,manuscript,text,1,O=C(O)CCCCC(=O)O,,,,increases,manuscript,figure 5b,5
Zheng2024,10.1021/acsomega.4c03864,1,"Chenxuan Zheng, Hao Wang, Ziyao Xiao, Zhixiong Sun, Junjie Bao, Wenjuan Dai, Qi Zhang, Xuefeng Mei",Cocrystal of Lutein with Improved Stability and Bioavailability,ACS Omega,2024,36389,1,MLT-APC,manuscript,text,2,1:1,manuscript,text,5,Lutein,manuscript,text,1,CC1=CC(O)CC(C)(C)C1/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C,manuscript,scheme 1,1,adipic acid,manuscript,text,1,O=C(O)CCCCC(=O)O,,,,increases,manuscript,figure 5b,5
Kawabata2023,10.1016/j.jpap.2023.100172,1,"Kohei Kawabata, Ayano Miyoshi, Hiroyuki Nishi",Cocrystallization with nicotinamide promotes naproxen photodegradation in the solid-state,Journal of Photochemistry and Photobiology,2023,100172,1,NPX-NA,manuscript,text,1,2:1,,,,naproxen,manuscript,text,1,COc1ccc2cc([C@H](C)C(=O)O)ccc2c1,manuscript,figure 1,2,nicotinamide,manuscript,text,1,NC(=O)c1cccnc1,manuscript,figure 1,2,decreases,manuscript,text,6
Yu2017,10.1039/C7CC06992H,1,"Qihui Yu, Zhicheng Yan, Junjie Bao, Jian-Rong Wang, Xuefeng Mei",Taming photo-induced oxidation degradation of dihydropyridine drugs through cocrystallization,Chemical Communications,2017,12266,0,NFD·INA form I,manuscript,text,3,1:1,manuscript,text,3,nifedipine,manuscript,text,2,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],manuscript,scheme 1,3,isonicotinamide,manuscript,text,2,NC(=O)c1ccncc1,supporting information,scheme s1,6,increases,manuscript,figure 1c,4
Yu2017,10.1039/C7CC06992H,1,"Qihui Yu, Zhicheng Yan, Junjie Bao, Jian-Rong Wang, Xuefeng Mei",Taming photo-induced oxidation degradation of dihydropyridine drugs through cocrystallization,Chemical Communications,2017,12266,0,NFD·INA form II,manuscript,text,3,1:1,manuscript,text,3,nifedipine,manuscript,text,2,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-],manuscript,scheme 1,3,isonicotinamide,manuscript,text,2,NC(=O)c1ccncc1,supporting information,scheme s1,6,decreases,manuscript,figure 1c,4
Vangala2011,10.1039/C0CE00772B,1,"Venu R. Vangala, Pui Shan Chowa, Reginald B. H. Tan","Characterization, physicochemical and photo-stability of a co-crystal involving an antibiotic drug, nitrofurantoin, and 4-hydroxybenzoic acid",CrystEngComm,2011,759,0,NF-4HBA,manuscript,text,2,1 : 1,manuscript,text,1,Nitrofurantoin,manuscript,text,1,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,manuscript,scheme 1,1,4-hydroxybenzoic acid,manuscript,text,1,O=C(O)c1ccc(O)cc1,manuscript,scheme 1,1,increases,manuscript,figure 5,3
Vangala2012,10.1021/cg300887p,1,"Venu R. Vangala, Pui Shan Chow, Reginald B. H. Tan",Co-Crystals and Co-Crystal Hydrates of the Antibiotic Nitrofurantoin: Structural Studies and Physicochemical Properties,Crystal Growth & Design,2012,5925,0,NF-3ABA,manuscript,text,1,1:1,manuscript,text,5,Nitrofurantoin,manuscript,text,1,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,manuscript,scheme 1,2,3-aminobenzoic acid,manuscript,text,1,Nc1cccc(C(=O)O)c1,manuscript,scheme 1,2,increases,manuscript,figure 15,12
Vangala2012,10.1021/cg300887p,1,"Venu R. Vangala, Pui Shan Chow, Reginald B. H. Tan",Co-Crystals and Co-Crystal Hydrates of the Antibiotic Nitrofurantoin: Structural Studies and Physicochemical Properties,Crystal Growth & Design,2012,5925,0,NF-4ABA,manuscript,text,1,1:1,manuscript,text,5,Nitrofurantoin,manuscript,text,1,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,manuscript,scheme 1,2,4-aminobenzoic acid,manuscript,text,1,Nc1ccc(C(=O)O)cc1,manuscript,scheme 1,2,increases,manuscript,figure 15,12
Vangala2012,10.1021/cg300887p,1,"Venu R. Vangala, Pui Shan Chow, Reginald B. H. Tan",Co-Crystals and Co-Crystal Hydrates of the Antibiotic Nitrofurantoin: Structural Studies and Physicochemical Properties,Crystal Growth & Design,2012,5925,0,NF-UREA,manuscript,text,1,1:1,manuscript,text,6,Nitrofurantoin,manuscript,text,1,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,manuscript,scheme 1,2,urea,manuscript,text,1,NC(N)=O,manuscript,scheme 1,2,increases,manuscript,figure 15,12
Vangala2012,10.1021/cg300887p,1,"Venu R. Vangala, Pui Shan Chow, Reginald B. H. Tan",Co-Crystals and Co-Crystal Hydrates of the Antibiotic Nitrofurantoin: Structural Studies and Physicochemical Properties,Crystal Growth & Design,2012,5925,0,NF-4HBAM,manuscript,text,1,1:2,manuscript,text,6,Nitrofurantoin,manuscript,text,1,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,manuscript,scheme 1,2,4-hydroxybenzamide,manuscript,text,1,NC(=O)c1ccc(O)cc1,manuscript,scheme 1,2,increases,manuscript,figure 15,12
Surov2022,10.1021/acs.cgd.2c00044,1,"Artem O. Surov, Alexander P. Voronin, Ksenia V. Drozd, Tatyana V. Volkova, Nikita Vasilev, Dmitriy Batov, Andrei V. Churakov, German L. Perlovich",Extending the Range of Nitrofurantoin Solid Forms: Effect of Molecular and Crystal Structure on Formation Thermodynamics and Physicochemical Properties,Crystal Growth & Design,2022,2569,0,[NFT-iNA] (1:1),manuscript,text,3,1:1,manuscript,text,2,Nitrofurantoin,manuscript,text,1,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,manuscript,figure 1,2,isonicotinamide,manuscript,text,1,NC(=O)c1ccncc1,manuscript,figure 1,2,increases,supporting inofrmation,figure s11,20
Surov2022,10.1021/acs.cgd.2c00044,1,"Artem O. Surov, Alexander P. Voronin, Ksenia V. Drozd, Tatyana V. Volkova, Nikita Vasilev, Dmitriy Batov, Andrei V. Churakov, German L. Perlovich",Extending the Range of Nitrofurantoin Solid Forms: Effect of Molecular and Crystal Structure on Formation Thermodynamics and Physicochemical Properties,Crystal Growth & Design,2022,2569,0,[NFT-PicAm](1:1),manuscript,text,3,1:1,manuscript,text,2,Nitrofurantoin,manuscript,text,1,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,manuscript,figure 1,2,picolinamide,manuscript,text,1,NC(=O)c1ccccn1,manuscript,figure 1,2,increases,supporting inofrmation,figure s11,20
Surov2022,10.1021/acs.cgd.2c00044,1,"Artem O. Surov, Alexander P. Voronin, Ksenia V. Drozd, Tatyana V. Volkova, Nikita Vasilev, Dmitriy Batov, Andrei V. Churakov, German L. Perlovich",Extending the Range of Nitrofurantoin Solid Forms: Effect of Molecular and Crystal Structure on Formation Thermodynamics and Physicochemical Properties,Crystal Growth & Design,2022,2569,0,[NFT-2AmBZA](1:1),manuscript,text,2,1:1,manuscript,text,2,Nitrofurantoin,manuscript,text,1,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,manuscript,figure 1,2,2-aminobenzamide,manuscript,text,1,NC(=O)c1ccccc1N,manuscript,figure 1,2,increases,supporting inofrmation,figure s11,20
Surov2022,10.1021/acs.cgd.2c00044,1,"Artem O. Surov, Alexander P. Voronin, Ksenia V. Drozd, Tatyana V. Volkova, Nikita Vasilev, Dmitriy Batov, Andrei V. Churakov, German L. Perlovich",Extending the Range of Nitrofurantoin Solid Forms: Effect of Molecular and Crystal Structure on Formation Thermodynamics and Physicochemical Properties,Crystal Growth & Design,2022,2569,0,[NFT-2OHBZA](1:1),manuscript,text,3,1:1,manuscript,text,2,Nitrofurantoin,manuscript,text,1,O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1,manuscript,figure 1,2,2-hydroxybenzamide,manuscript,text,1,NC(=O)c1ccccc1O,manuscript,figure 1,2,increases,supporting inofrmation,figure s11,20
Li2020,10.1002/anie.202009714,1,"Shuzhen Li, Bo Lu, Xiaoyu Fang, Dongpeng Yan",Manipulating Light-Induced Dynamic Macro-Movement and Static Photonic Properties within 1D Isostructural Hydrogen-Bonded Molecular Cocrystals,Angewandte Chemie International Edition,2020,22623,1,NVP-THA,manuscript,text,1,1:2,manuscript,text,1,4-(1-naphthylvinyl)pyridine,manuscript,text,1,C(=C/c1cccc2ccccc12)\c1ccncc1,manuscript,figure 1,2,"2,3,5,6-tetrafluorobenzoic acid",manuscript,figure 1,2,O=C(O)c1c(F)c(F)cc(F)c1F,manuscript,figure 1,2,does not change,manuscript,text,1
Cugovčan2017,10.1016/j.jpba.2017.01.025,1,"Martina Cugovčan, Jasna Jablan, Jasmina Lovrić, Dominik Cinčić, Nives Galić, Mario Jug",Biopharmaceutical characterization of praziquantel cocrystals and cyclodextrin complexes prepared by grinding,Journal of Pharmaceutical and Biomedical Analysis,2017,42,1,PZQ/MA,manuscript,text,4,1:1,manuscript,table 1,4,praziquantel,manuscript,text,1,O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1,,,,malic acid,manuscript,text,2,O=C(O)CC(O)C(=O)O,,,,decreases,manuscript,figure 5b,9
Ambrogi2014,10.1021/la5033898,0,"Valeria Ambrogi, Morena Nocchetti, Loredana Latterini",Promethazine–Montmorillonite Inclusion Complex To Enhance Drug Photostability,Langmuir,2014,14612,0,MONT-PRO,manuscript,text,1,,,,,Promethazine,manuscript,text,1,CC(CN1c2ccccc2Sc2ccccc21)N(C)C,manuscript,figure 1,1,Montmorillonite,,,,nan,,,,does not change,manuscript,figure 10,7
Qu2024,10.1016/j.cej.2024.151902,1,"Haibin Qu, Ye Gao, Lina Zhou, Songgu Wu, Junbo Gong",Construction of fungicide nano delivery platform through crystal engineering for sustainable fungal control,Chemical Engineering Journal,2024,151902,1,PYR-FMA,manuscript,text,3,1:2,supporting information,text,3,pyrimethanil,manuscript,text,1,Cc1cc(C)nc(Nc2ccccc2)n1,manuscript,figure 1,3,fumaric acid,manuscript,text,2,O=C(O)/C=C/C(=O)O,manuscript,figure 1,3,increases,manuscript,figure 7b,9
Qu2024,10.1016/j.cej.2024.151902,1,"Haibin Qu, Ye Gao, Lina Zhou, Songgu Wu, Junbo Gong",Construction of fungicide nano delivery platform through crystal engineering for sustainable fungal control,Chemical Engineering Journal,2024,151902,1,PYR-3IA,manuscript,text,3,1:1,supporting information,text,3,pyrimethanil,manuscript,text,1,Cc1cc(C)nc(Nc2ccccc2)n1,manuscript,figure 1,3,indole-3-acetic acid,manuscript,text,2,O=C(O)Cc1c[nH]c2ccccc12,manuscript,figure 1,3,increases,manuscript,figure 7b,9
Dhakar2019,10.3390/pharmaceutics11100545,0,"Nilesh Kumar Dhakar, Adrián Matencio,Fabrizio Caldera, Monica Argenziano, Roberta Cavalli, Chiara Dianzani, Marco Zanetti, José Manuel López-Nicolás, Francesco Trotta","Comparative Evaluation of Solubility, Cytotoxicity and Photostability Studies of Resveratrol and Oxyresveratrol Loaded Nanosponge",Pharmaceutics,2019,545,1,RES-NS,manuscript,text,6,,,,,resveratrol,manuscript,text,1,Oc1ccc(C=Cc2cc(O)cc(O)c2)cc1,manuscript,figure 1,2,nanosponge,manuscript,text,1,nan,,,,increases,manuscript,figure 9a,10
Dhakar2019,10.3390/pharmaceutics11100545,0,"Nilesh Kumar Dhakar, Adrián Matencio,Fabrizio Caldera, Monica Argenziano, Roberta Cavalli, Chiara Dianzani, Marco Zanetti, José Manuel López-Nicolás, Francesco Trotta","Comparative Evaluation of Solubility, Cytotoxicity and Photostability Studies of Resveratrol and Oxyresveratrol Loaded Nanosponge",Pharmaceutics,2019,545,1,OXY-NS,manuscript,text,6,,,,,oxyresveratrol,manuscript,text,1,Oc1cc(O)cc(C=Cc2ccc(O)cc2O)c1,manuscript,figure 1,2,nanosponge,manuscript,text,1,nan,,,,increases,manuscript,figure 9b,10
Muthaiyan2024,10.1021/acs.cgd.4c00855,1,"Muthukumari Muthaiyan, Fayaz T. K. S, Gowtham Kenguva, Aditya Kumar Prajapati, Rambabu Dandela, Vladimir V. Chernyshev, Palash Sanphui",New Multicomponent Solid Forms of the Antitumor Drug Ripretinib: The Role of Conformations in Dictating Dissolution and Photostability,Crystal Growth & Design,2024,7617,0,RIP-HCl,manuscript,text,2,1:1,manuscript,text,5,Ripretinib,manuscript,text,1,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21,manuscript,figure 1,2,HCl,manuscript,text,2,Cl,manuscript,figure 1,2,increases,manuscript,figure 10,12
Muthaiyan2024,10.1021/acs.cgd.4c00855,1,"Muthukumari Muthaiyan, Fayaz T. K. S, Gowtham Kenguva, Aditya Kumar Prajapati, Rambabu Dandela, Vladimir V. Chernyshev, Palash Sanphui",New Multicomponent Solid Forms of the Antitumor Drug Ripretinib: The Role of Conformations in Dictating Dissolution and Photostability,Crystal Growth & Design,2024,7617,0,RIP-FOR,manuscript,text,3,1:2,manuscript,text,7,Ripretinib,manuscript,text,1,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21,manuscript,figure 1,2,formic acid,manuscript,text,3,O=CO,manuscript,figure 1,2,increases,manuscript,figure 10,12
Muthaiyan2024,10.1021/acs.cgd.4c00855,1,"Muthukumari Muthaiyan, Fayaz T. K. S, Gowtham Kenguva, Aditya Kumar Prajapati, Rambabu Dandela, Vladimir V. Chernyshev, Palash Sanphui",New Multicomponent Solid Forms of the Antitumor Drug Ripretinib: The Role of Conformations in Dictating Dissolution and Photostability,Crystal Growth & Design,2024,7617,0,RIP-AA,manuscript,text,3,1:1,manuscript,text,7,Ripretinib,manuscript,text,1,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21,manuscript,figure 1,2,acetic acid,manuscript,text,3,CC(=O)O,manuscript,figure 1,2,increases,manuscript,figure 10,12
Muthaiyan2024,10.1021/acs.cgd.4c00855,1,"Muthukumari Muthaiyan, Fayaz T. K. S, Gowtham Kenguva, Aditya Kumar Prajapati, Rambabu Dandela, Vladimir V. Chernyshev, Palash Sanphui",New Multicomponent Solid Forms of the Antitumor Drug Ripretinib: The Role of Conformations in Dictating Dissolution and Photostability,Crystal Growth & Design,2024,7617,0,RIP-DHBA,manuscript,text,3,1:1,,,,Ripretinib,manuscript,text,1,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21,manuscript,figure 1,2,"2,6-dihydroxybenzoic acid",manuscript,text,4,O=C(O)c1c(O)cccc1O,manuscript,figure 1,2,increases,manuscript,figure 10,12
Muthaiyan2024,10.1021/acs.cgd.4c00855,1,"Muthukumari Muthaiyan, Fayaz T. K. S, Gowtham Kenguva, Aditya Kumar Prajapati, Rambabu Dandela, Vladimir V. Chernyshev, Palash Sanphui",New Multicomponent Solid Forms of the Antitumor Drug Ripretinib: The Role of Conformations in Dictating Dissolution and Photostability,Crystal Growth & Design,2024,7617,0,RIP-FER,manuscript,text,3,1:1,manuscript,text,9,Ripretinib,manuscript,text,1,CCn1c(=O)c(-c2cc(NC(=O)Nc3ccccc3)c(F)cc2Br)cc2cnc(NC)cc21,manuscript,figure 1,2,ferulic acid,manuscript,text,3,COc1cc(/C=C/C(=O)O)ccc1O,manuscript,figure 1,2,increases,manuscript,figure 10,12
Muthusamy2024,10.1016/j.xphs.2023.10.024,1,"Anantha Rajmohan Muthusamy, Amit Singha, Meenakshi Sundaram Soma Sundarama, Yogesh Wagha, Alexandr Jegorovb, Arvind Kumar Jain",In-Silico Aided Screening and Characterization Results in Stability Enhanced Novel Roxadustat Co-Crystal,Journal of Pharmaceutical Sciences,2024,1190,0,RXD-NA,manuscript,text,1,1:1,manuscript,text,8,Roxadustat,manuscript,text,1,Cc1nc(C(=O)NCC(=O)O)c(O)c2ccc(Oc3ccccc3)cc12,manuscript,figure 1,3,nicotinamide,manuscript,text,1,NC(=O)c1cccnc1,manuscript,figure 1,3,increases,manuscript,table 6,10
Kalle2024,10.1021/acs.cgd.4c01197,1,"Paulina Kalle, Stanislav I. Bezzubov, Lyudmila G. Kuzmina, Andrei V. Churakov","New Insights into the Structure, Thermal Properties, and Photostability of Industrially Relevant Salts of Sorbic Acid",Crystal Growth & Design,2024,9173,0,NaSorb,manuscript,text,2,,,,,Sorbic Acid,manuscript,text,1,C/C=C/C=C/C(=O)O,,,,sodium,manuscript,text,2,nan,,,,does not change,supporting information,figure s2,6
Kalle2024,10.1021/acs.cgd.4c01197,1,"Paulina Kalle, Stanislav I. Bezzubov, Lyudmila G. Kuzmina, Andrei V. Churakov","New Insights into the Structure, Thermal Properties, and Photostability of Industrially Relevant Salts of Sorbic Acid",Crystal Growth & Design,2024,9173,0,KSorb,manuscript,text,2,,,,,Sorbic Acid,manuscript,text,1,C/C=C/C=C/C(=O)O,,,,Potassium,manuscript,text,2,nan,,,,decreases,supporting information,figure s3,7
Kalle2024,10.1021/acs.cgd.4c01197,1,"Paulina Kalle, Stanislav I. Bezzubov, Lyudmila G. Kuzmina, Andrei V. Churakov","New Insights into the Structure, Thermal Properties, and Photostability of Industrially Relevant Salts of Sorbic Acid",Crystal Growth & Design,2024,9173,0,CaSorb,manuscript,text,2,,,,,Sorbic Acid,manuscript,text,1,C/C=C/C=C/C(=O)O,,,,calcium,manuscript,text,2,nan,,,,does not change,supporting information,figure s4,7
Kalle2024,10.1021/acs.cgd.4c01197,1,"Paulina Kalle, Stanislav I. Bezzubov, Lyudmila G. Kuzmina, Andrei V. Churakov","New Insights into the Structure, Thermal Properties, and Photostability of Industrially Relevant Salts of Sorbic Acid",Crystal Growth & Design,2024,9173,0,NH4Sorb·HSorb,manuscript,text,2,,,,,Sorbic Acid,manuscript,text,1,C/C=C/C=C/C(=O)O,,,,Ammonium,manuscript,text,2,[NH4+],manuscript,text,2,decreases,supporting information,figure s5,8
Geng2013,10.1021/cg400518w,1,"Na Geng, Jia-Mei Chen, Zi-Jian Li, Long Jiang, Tong-Bu Lu",Approach of cocrystallization to improve the solubility and photostability of tranilast,Crystal Growth & Design,2013,3546,0,1,manuscript,text,3,1:1,manuscript,text,3,Tranilast,manuscript,text,1,COc1ccc(C=CC(=O)Nc2ccccc2C(=O)O)cc1OC,manuscript,figure 1,2,Urea,manuscript,text,1,NC(N)=O,manuscript,figure 1,2,increases,manuscript,figure 8,7
Geng2013,10.1021/cg400518w,1,"Na Geng, Jia-Mei Chen, Zi-Jian Li, Long Jiang, Tong-Bu Lu",Approach of cocrystallization to improve the solubility and photostability of tranilast,Crystal Growth & Design,2013,3546,0,2,manuscript,text,3,1:1,manuscript,text,3,Tranilast,manuscript,text,1,COc1ccc(C=CC(=O)Nc2ccccc2C(=O)O)cc1OC,manuscript,figure 1,2,Nicotinamide,manuscript,text,1,NC(=O)c1cccnc1,manuscript,figure 1,2,increases,manuscript,figure 8,7
Geng2013,10.1021/cg400518w,1,"Na Geng, Jia-Mei Chen, Zi-Jian Li, Long Jiang, Tong-Bu Lu",Approach of cocrystallization to improve the solubility and photostability of tranilast,Crystal Growth & Design,2013,3546,0,3,manuscript,text,3,1:1,manuscript,text,3,Tranilast,manuscript,text,1,COc1ccc(C=CC(=O)Nc2ccccc2C(=O)O)cc1OC,manuscript,figure 1,2,Cytosine,manuscript,text,1,Nc1cc[nH]c(=O)n1,manuscript,figure 1,2,increases,manuscript,figure 8,7
Geng2013,10.1021/cg400518w,1,"Na Geng, Jia-Mei Chen, Zi-Jian Li, Long Jiang, Tong-Bu Lu",Approach of cocrystallization to improve the solubility and photostability of tranilast,Crystal Growth & Design,2013,3546,0,4,manuscript,text,3,,,,,Tranilast,manuscript,text,1,COc1ccc(C=CC(=O)Nc2ccccc2C(=O)O)cc1OC,manuscript,figure 1,2,Sodium,manuscript,text,1,nan,,,,increases,manuscript,figure 8,7
bofill2021,10.1021/acs.cgd.0c01709,1,"Lídia Bofill, Dafne de Sande, Rafael Barbas, Rafel Prohens",A New and Highly Stable Cocrystal of Vitamin D3 for Use in Enhanced Food Supplements,Crystal Growth & Design,2021,1418,0,Vitamin D3−Resorcinol cocrystal,manuscript,text,2,1:1,supporting information,text,2,cholecalciferol,manuscript,text,1,C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12,manuscript,figure 1,3,resorcinol,manuscript,text,1,Oc1cccc(O)c1,manuscript,figure 1,3,increases,manuscript,figure 3,4
zhu2016,10.1021/acs.cgd.5b01491,1,"Bingqing Zhu, Jian-Rong Wang, Qi Zhang, Xuefeng Mei",Improving Dissolution and Photostability of Vitamin K3 via Cocrystallization with Naphthoic Acids and Sulfamerazine,Crystal Growth & Design,2015,483,0,MD·1-HNA,manuscript,text,4,,,,,Menadione,manuscript,text,1,CC1=CC(=O)c2ccccc2C1=O,manuscript,scheme 1,1,1-Hydroxy-2-naphthoic Acid,manuscript,text,2,O=C(O)c1ccc2ccccc2c1O,manuscript,scheme 2,2,increases,manuscript,figure 12,9
zhu2016,10.1021/acs.cgd.5b01491,1,"Bingqing Zhu, Jian-Rong Wang, Qi Zhang, Xuefeng Mei",Improving Dissolution and Photostability of Vitamin K3 via Cocrystallization with Naphthoic Acids and Sulfamerazine,Crystal Growth & Design,2015,483,0,MD·6-HNA,manuscript,text,4,,,,,Menadione,manuscript,text,1,CC1=CC(=O)c2ccccc2C1=O,manuscript,scheme 1,1,6-Hydroxy-2-naphthoic Acid,manuscript,text,2,O=C(O)c1ccc2cc(O)ccc2c1,manuscript,scheme 2,2,increases,supporting information,figure S8a,11
zhu2016,10.1021/acs.cgd.5b01491,1,"Bingqing Zhu, Jian-Rong Wang, Qi Zhang, Xuefeng Mei",Improving Dissolution and Photostability of Vitamin K3 via Cocrystallization with Naphthoic Acids and Sulfamerazine,Crystal Growth & Design,2015,483,0,MD·Sul,manuscript,text,4,,,,,Menadione,manuscript,text,1,CC1=CC(=O)c2ccccc2C1=O,manuscript,scheme 1,1,Sulfamerazine,manuscript,text,2,Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1,manuscript,scheme 2,2,increases,supporting information,figure S8b,11